A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
A multinational collaboration co-led by the Garvan Institute of Medical Research, in collaboration with Rockefeller University, and Kyoto University Graduate School of Medicine, has uncovered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results